AI innovation “Sturgeon” transforms classification of central nervous system malignancies

Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of CNS malignancies.

PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million – Biotech Investments

EQS-News: PAION AG / Key word(s): Capital Increase PAION AG announces fully underwritten rights issue with target gross proceeds of EUR 10 million 13.10.2023 /

October 14, 2023

Should I Offer My Patient the Option to End His Life?

Listen and subscribe/follow on Apple and Spotify so you don’t miss the next episode. And if you like what you hear, a five-star rating goes

October 26, 2024

Q&A: FDA chief on why our hearts are less healthy, how obesity drugs impress him, and what worries him

Robert Califf, a cardiologist and commissioner of the U.S. Food and Drug Administration, has been deeply involved in cardiovascular research: investigating health outcomes, health care

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.